Total Payments
$997.66
2024 Payments
$139.34
Companies
14
Transactions
28
Medicare Patients
120
Medicare Billing
$5,775
Payment Breakdown by Category
Food & Beverage$997.66 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $997.66 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galt Pharmaceuticals, LLC | $457.40 | 1 | $0 (2023) |
| ABBVIE INC. | $121.11 | 6 | $0 (2024) |
| Novo Nordisk Inc | $63.27 | 3 | $0 (2023) |
| ITI, Inc. | $58.22 | 3 | $0 (2023) |
| Harmony Biosciences LLC | $56.03 | 3 | $0 (2023) |
| Atland Pharmaceuticals, LLC | $48.58 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $40.66 | 2 | $0 (2024) |
| PFIZER INC. | $38.59 | 2 | $0 (2023) |
| Antares Pharma, Inc. | $35.47 | 2 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $24.37 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.34 | 6 | ABBVIE INC. ($61.25) |
| 2023 | $759.82 | 17 | Galt Pharmaceuticals, LLC ($457.40) |
| 2022 | $98.50 | 5 | Harmony Biosciences LLC ($32.92) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Atland Pharmaceuticals, LLC | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE (Drug), TOLMETIN SODIUM | Food and Beverage | In-kind items and services | $48.58 | General |
| Category: Pain | ||||||
| 05/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: PSYCHIATRY | ||||||
| 03/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: PSYCHIATRY | ||||||
| 03/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: PAIN | ||||||
| 12/09/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.37 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/28/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: PAIN | ||||||
| 09/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Diabetes | ||||||
| 09/07/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.11 | General |
| Category: SLEEP MEDICINE | ||||||
| 08/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Diabetes | ||||||
| 07/20/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: PSYCHIATRY | ||||||
| 06/01/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/23/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 04/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: PSYCHIATRY | ||||||
| 03/13/2023 | Galt Pharmaceuticals, LLC | Orphengesic Forte (Drug), Oravig | Food and Beverage | In-kind items and services | $457.40 | General |
| Category: Pain | ||||||
| 03/09/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 02/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diabetes | ||||||
| 01/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2022 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $16.72 | General |
| Category: Neurological Disorders | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 103 | 263 | $12,360 | $4,588 |
| 2022 | 1 | 17 | 21 | $2,636 | $1,187 |
Total Patients
120
Total Services
284
Medicare Billing
$5,775
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 30 | $5,160 | $1,923 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 30 | $3,600 | $1,479 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,090 | $864.92 | 41.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 35 | $1,338 | $293.15 | 21.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 52 | $67.60 | $17.97 | 26.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 105 | $105.00 | $9.36 | 8.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 21 | $2,636 | $1,187 | 45.1% |
About Emily Etheridge
Emily Etheridge is a Family healthcare provider based in Baileyton, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2021. The National Provider Identifier (NPI) number assigned to this provider is 1770258287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Etheridge has received a total of $997.66 in payments from pharmaceutical and medical device companies, with $139.34 received in 2024. These payments were reported across 28 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($997.66).
As a Medicare-enrolled provider, Etheridge has provided services to 120 Medicare beneficiaries, totaling 284 services with total Medicare billing of $5,775. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Baileyton, AL
- Active Since 08/16/2021
- Last Updated 08/16/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1770258287
Products in Payments
- Orphengesic Forte (Drug) $457.40
- VRAYLAR (Drug) $100.84
- CAPLYTA (Drug) $71.45
- ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE (Drug) $48.58
- Rybelsus (Drug) $45.52
- REXULTI (Drug) $40.66
- NURTEC ODT (Drug) $38.59
- NOCDURNA (Drug) $35.47
- Wakix (Drug) $32.92
- JORNAY PM (Drug) $24.37
- WAKIX (Drug) $23.11
- QULIPTA (Drug) $20.27
- Ozempic (Drug) $17.75
- MOUNJARO (Drug) $14.23
- BREZTRI (Drug) $13.46
- XYOSTED (Drug) $13.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.